Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: GEH121224 (18F) Injection|DIAGNOSTIC_TEST: Dynamic and Static - PET/CT Scan|DIAGNOSTIC_TEST: Static - PET/CT Scan
Sponsor: GE Healthcare
Collaborators: Laboratory Corporation of America